Asmaa K. Amin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Asmaa K. Amin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Anna Lengyel
Semmelweis University: Semmelweis Egyetem
1 shared publication - Annette Lischka
Institute for Human Genetics and Genomic Medicine, RWTH Aachen University, Aachen, Germany
1 shared publication - Cordula Knopp
Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany
1 shared publication - Eva Pinti
2nd Department of Pediatrics Semmelweis University Budapest Hungary
1 shared publication - Florian Kraft
Center for Human Genetics and Genomic Medicine, Faculty of Medicine, RWTH Aachen University, Aachen, Germany
1 shared publication - Gyorgy Fekete
2nd Department of Pediatrics Semmelweis University Budapest Hungary
1 shared publication
Latest Publications
- Open Access
- 12 December 2024
- Published by Wiley in Clinical Genetics
- Vol. 107 (3) , 278-291
Diagnostic Use of Genome Sequencing in Patients With 11p15.5 Imprinting Disorder Features: A Pilot Study
To assess the suitability of genome sequencing (GS) as the second step in the diagnostics of patients with the features of 11p15.5‐associated imprinting disorders (ImpDis: Silver–Russell syndrome [SRS], Beckwith–Wiedemann syndrome [BWS]), we performed short‐read GS in patients negatively tested for imprinting disturbances. Obtaining a genetic diagnosis for patients with the features of these syndromes is challenging due to the clinical and molecular heterogeneity and overlap, and many patients remain undiagnosed after the currently suggested stepwise diagnostic workup. GS was conducted in 48 patients (SRS features: n = 37 and BWS features: n = 11). The detection rate differed markedly between the ImpDis: although a genetic cause could be identified in 51% of patients referred with SRS features, no pathogenic variants were detected in patients with BWS features. Thus, GS substantially improves the diagnostic yield and broadens the spectrum of overlapping disorders with SRS features. Obtaining a precise molecular diagnosis provides the basis for a personalized clinical management. Our findings support the use of GS as a second‐tier diagnostic tool for patients with growth disturbances, as it addresses all currently known variant types and shortens the diagnostic odyssey.
- 12 December 2024
- Published by Wiley in Clinical Genetics
- Vol. 107 (3) , 278-291
Open AccessDiagnostic Use of Genome Sequencing in Patients With 11p15.5 Imprinting Disorder Features: A Pilot Study
To assess the suitability of genome sequencing (GS) as the second step in the diagnostics of patients with the features of 11p15.5‐associated imprinting disorders (ImpDis: Silver–Russell syndrome [SRS], Beckwith–Wiedemann syndrome [BWS]), we performed short‐read GS in patients negatively tested for imprinting disturbances. Obtaining a genetic diagnosis for patients with the features of these syndromes is challenging due to the clinical and molecular heterogeneity and overlap, and many patients remain undiagnosed after the currently suggested stepwise diagnostic workup. GS was conducted in 48 patients (SRS features: n = 37 and BWS features: n = 11). The detection rate differed markedly between the ImpDis: although a genetic cause could be identified in 51% of patients referred with SRS features, no pathogenic variants were detected in patients with BWS features. Thus, GS substantially improves the diagnostic yield and broadens the spectrum of overlapping disorders with SRS features. Obtaining a precise molecular diagnosis provides the basis for a personalized clinical management. Our findings support the use of GS as a second‐tier diagnostic tool for patients with growth disturbances, as it addresses all currently known variant types and shortens the diagnostic odyssey.